vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and GENCOR INDUSTRIES INC (GENC). Click either name above to swap in a different company.
GENCOR INDUSTRIES INC is the larger business by last-quarter revenue ($23.6M vs $19.2M, roughly 1.2× Apyx Medical Corp). GENCOR INDUSTRIES INC runs the higher net margin — 14.6% vs -6.8%, a 21.4% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -25.0%). GENCOR INDUSTRIES INC produced more free cash flow last quarter ($10.1M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -23.9%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.
APYX vs GENC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $23.6M |
| Net Profit | $-1.3M | $3.4M |
| Gross Margin | 62.6% | 28.7% |
| Operating Margin | 0.1% | 13.2% |
| Net Margin | -6.8% | 14.6% |
| Revenue YoY | 34.7% | -25.0% |
| Net Profit YoY | 71.9% | -9.8% |
| EPS (diluted) | — | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $23.6M | ||
| Q3 25 | $12.9M | $18.8M | ||
| Q2 25 | $11.4M | $27.0M | ||
| Q1 25 | $9.4M | $38.2M | ||
| Q4 24 | $14.2M | $31.4M | ||
| Q3 24 | $11.5M | $20.9M | ||
| Q2 24 | $12.1M | $25.6M | ||
| Q1 24 | $10.2M | $40.7M |
| Q4 25 | $-1.3M | $3.4M | ||
| Q3 25 | $-2.0M | $1.9M | ||
| Q2 25 | $-3.8M | $3.8M | ||
| Q1 25 | $-4.2M | $6.1M | ||
| Q4 24 | $-4.6M | $3.8M | ||
| Q3 24 | $-4.7M | $1.5M | ||
| Q2 24 | $-6.6M | $2.6M | ||
| Q1 24 | $-7.6M | $6.2M |
| Q4 25 | 62.6% | 28.7% | ||
| Q3 25 | 64.4% | 24.2% | ||
| Q2 25 | 62.3% | 26.5% | ||
| Q1 25 | 60.1% | 29.7% | ||
| Q4 24 | 63.0% | 27.6% | ||
| Q3 24 | 60.5% | 25.6% | ||
| Q2 24 | 61.7% | 23.9% | ||
| Q1 24 | 58.1% | 30.3% |
| Q4 25 | 0.1% | 13.2% | ||
| Q3 25 | -6.5% | -1.2% | ||
| Q2 25 | -22.6% | 11.6% | ||
| Q1 25 | -32.4% | 17.0% | ||
| Q4 24 | -21.4% | 14.7% | ||
| Q3 24 | -31.6% | 5.9% | ||
| Q2 24 | -45.7% | 7.8% | ||
| Q1 24 | -64.6% | 17.4% |
| Q4 25 | -6.8% | 14.6% | ||
| Q3 25 | -15.4% | 10.2% | ||
| Q2 25 | -33.2% | 14.2% | ||
| Q1 25 | -44.0% | 16.0% | ||
| Q4 24 | -32.5% | 12.1% | ||
| Q3 24 | -40.9% | 6.9% | ||
| Q2 24 | -54.0% | 10.0% | ||
| Q1 24 | -74.0% | 15.3% |
| Q4 25 | — | $0.23 | ||
| Q3 25 | — | $0.13 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.42 | ||
| Q4 24 | — | $0.26 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | $-0.19 | $0.17 | ||
| Q1 24 | $-0.22 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $147.7M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $215.2M |
| Total Assets | $66.8M | $228.9M |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $147.7M | ||
| Q3 25 | $25.1M | $136.3M | ||
| Q2 25 | $29.3M | $136.0M | ||
| Q1 25 | $31.0M | $143.7M | ||
| Q4 24 | $31.7M | $130.1M | ||
| Q3 24 | $28.0M | $115.4M | ||
| Q2 24 | $32.7M | $116.6M | ||
| Q1 24 | $37.3M | $117.1M |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | $0 | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | $0 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $215.2M | ||
| Q3 25 | $5.8M | $211.8M | ||
| Q2 25 | $7.3M | $209.9M | ||
| Q1 25 | $10.5M | $206.1M | ||
| Q4 24 | $14.2M | $200.0M | ||
| Q3 24 | $11.0M | $196.1M | ||
| Q2 24 | $14.7M | $194.7M | ||
| Q1 24 | $20.3M | $192.1M |
| Q4 25 | $66.8M | $228.9M | ||
| Q3 25 | $57.4M | $222.6M | ||
| Q2 25 | $58.2M | $220.2M | ||
| Q1 25 | $60.2M | $223.9M | ||
| Q4 24 | $64.8M | $218.2M | ||
| Q3 24 | $60.7M | $208.1M | ||
| Q2 24 | $65.4M | $201.8M | ||
| Q1 24 | $70.7M | $206.0M |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | 0.00× | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $11.1M |
| Free Cash FlowOCF − Capex | $-2.8M | $10.1M |
| FCF MarginFCF / Revenue | -14.6% | 43.0% |
| Capex IntensityCapex / Revenue | 1.4% | 4.1% |
| Cash ConversionOCF / Net Profit | — | 3.23× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $-3.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $11.1M | ||
| Q3 25 | $-3.5M | $-275.0K | ||
| Q2 25 | $-1.2M | $-23.9M | ||
| Q1 25 | $-702.0K | $12.4M | ||
| Q4 24 | $-2.9M | $14.8M | ||
| Q3 24 | $-4.4M | $-3.2M | ||
| Q2 24 | $-4.3M | $-1.0M | ||
| Q1 24 | $-6.3M | $11.7M |
| Q4 25 | $-2.8M | $10.1M | ||
| Q3 25 | $-4.1M | $-1.3M | ||
| Q2 25 | $-1.5M | $-24.4M | ||
| Q1 25 | $-757.0K | $12.3M | ||
| Q4 24 | $-3.2M | $14.5M | ||
| Q3 24 | $-4.6M | $-3.3M | ||
| Q2 24 | $-4.6M | $-1.4M | ||
| Q1 24 | $-6.4M | $11.7M |
| Q4 25 | -14.6% | 43.0% | ||
| Q3 25 | -31.5% | -6.8% | ||
| Q2 25 | -13.2% | -90.4% | ||
| Q1 25 | -8.0% | 32.2% | ||
| Q4 24 | -22.4% | 46.1% | ||
| Q3 24 | -40.0% | -15.8% | ||
| Q2 24 | -38.0% | -5.6% | ||
| Q1 24 | -62.2% | 28.7% |
| Q4 25 | 1.4% | 4.1% | ||
| Q3 25 | 4.0% | 5.4% | ||
| Q2 25 | 2.3% | 1.8% | ||
| Q1 25 | 0.6% | 0.4% | ||
| Q4 24 | 1.7% | 1.0% | ||
| Q3 24 | 1.3% | 0.4% | ||
| Q2 24 | 2.4% | 1.5% | ||
| Q1 24 | 0.3% | 0.0% |
| Q4 25 | — | 3.23× | ||
| Q3 25 | — | -0.14× | ||
| Q2 25 | — | -6.24× | ||
| Q1 25 | — | 2.04× | ||
| Q4 24 | — | 3.88× | ||
| Q3 24 | — | -2.22× | ||
| Q2 24 | — | -0.41× | ||
| Q1 24 | — | 1.87× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
